fda semaglutide mash Big news in liver health! 📣 (metabolic dysfunction-associated steatohepatitis) is part of a group of metabolic liver diseases that has become the #1 cause of liver disease in America, and now The FDA has approved Wegovy

It takes time, effort and committed dietary, physical activity and other lifestyle changes to truly lose weight

Like other digestive symptoms (nausea, bloating, constipation), they usually improve as the body adjusts

The common side effects are more manageable and often fade after being on the medication for a few weeks, though not always for every person

Exploring GLP-1 Weight Loss Medications and Potential Side Effects Are you exploring lasting weight loss solutions

However, glucagon also: Increases energy expenditure: Glucagon promotes thermogenesis and fat oxidation Targets the liver directly: The liver has no GLP-1 or GIP receptors but is rich in glucagon receptors Reduces liver fat: Glucagon receptor activation may ease oxidative stress in liver mitochondria Provides anti-fibrotic benefits: Improved fat oxidation can improve mitochondrial function When combined with GLP-1 and GIP agonism, the glucagon components blood sugar effects appear to be counterbalanced while its metabolic benefits are retained

Also, researchers do not always ask about changes in menstrual cycles unless the study is focused on hormones or reproduction